Respiratory

The range of inhaled therapies has expanded dramatically in recent years.

Direct and concise information will dissuade dangerous use.

Fewer tracheobronchial branches may be a genetically-related risk factor.

Regular exercise can be an effective way to delay the onset and acceleration of COPD.

"I’ve yet to meet a pharmacist who ever had this covered in pharmacy school," writes Kreckel. 

Commercial launch suspended due to manufacturer liquidity.

The drug comes at a time when antibiotic resistance worries are high. Here’s why it matters.

Whether marijuana use increases COPD susceptibility remains uncertain.

Only 50% of COPD patients are estimated to be vaccinated.

New medications and treatment guidelines

Oral kinase inhibitor for SSc-ILD.

Imaging techniques, stem cell therapy, and more!

Prescriptions for COPD contribute to antimicrobial resistance.

New pleuromutilin antibiotic IV and oral tablets.

Natal conditions may influence susceptibility.

Updated guidelines shift assessment emphases.

Exciting and upcoming developments, years in the making.

New technology is making it possible to predict and respond to COPD flare ups. 

Working in an office may be a greater COPD risk than working in a mine. 

Twenty percent of patients with either or both asthma and COPD have an overlap of symptoms.

A three-year study finds that aspirin may have a role in preventing COPD flare ups.

Changes to vaccine recommendations for older adults may mean they have to pay for pneumococcal vaccine themselves.

Zerbaxa is a cephalosporin antibacterial and beta-lactamase inhibitor combination drug originally approved for abdominal and urinary tract infections.

DUAKLIR PRESSAIR (aclidinium bromide and formoterol fumarate) provides LAMA/LABA therapy.